1
The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period
Condition(s):Endometrial NeoplasmsLast Updated:August 25, 2021Active, not recruiting
Endometrial Neoplasms: 1040 Clinical Trials, Page 1 of 104
Hide Studies Not Open or Pending
2
Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique
Condition(s):Endometrial NeoplasmsLast Updated:February 10, 2021Recruiting
3
Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells
Condition(s):Metformin; CA EndometriumLast Updated:January 9, 2020Completed
4
Follow-up Care After Treatment for Endometrial Cancer
Condition(s):Endometrial NeoplasmLast Updated:July 13, 2012Completed
5
Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial Neoplasia
Condition(s):Hysterectomy; LaparoscopyLast Updated:October 9, 2018Completed
6
Studies of the Tumour Suppressor Gene PTEN – Endometrial Cancer
Condition(s):Endometrial NeoplasmsLast Updated:March 31, 2016Completed
7
Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer
Condition(s):Endometrial NeoplasmsLast Updated:October 19, 2021Recruiting
8
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
Condition(s):Endometrial NeoplasmsLast Updated:August 5, 2021Recruiting
9
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
Condition(s):Endometrial NeoplasmsLast Updated:January 13, 2022Recruiting
10
Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer
Condition(s):Endometrial NeoplasmsLast Updated:October 5, 2021Completed